Lumos Diagnostics Holdings Ltd. · ASX:LDX

Lumos Diagnostics — Investor Presentation (January 2024)

8 slides from Lumos Diagnostics's investor presentation, Jan 16, 2024

  1. Slide 1: Investor briefing: Major Development and IP Agreements with Hologic

    For personal use only Investor briefing: Major Development and IP Agreements with leading global women’s health company, Hologic, Inc. 16 January 2024 www.lumosdiagnostics.com Confidential 1

  2. Slide 2: Disclaimer and Important Information

    Disclaimer and Important Information This presentation (Presentation) has been prepared solely for informational purposes by Lumos Diagnostics Holdings Limited (Company). The information contained in this document (“Document”) has been prepared by Lumos Diagnostics Holdings Limited (referred to as “

  3. Slide 3: Company snapshot

    Company snapshot Lumos is a developer and manufacturer of connected instrumentation and rapid point-of-care tests for For personal use only the diagnostics and healthcare industries • Led by Doug Ward, industry veteran with over 30 years' experience in diagnostics • Comprehensive offering from conce

  4. Slide 4: Lumos' POC diagnostic test development engine

    Lumos’ POC diagnostic test development engine For personal use only Design Develop Manufacture Product concepts REVENUE Contract Fees Revenue & Margin Sales & License Payments STREAMS from services from manufacturing from own & other products 4

  5. Slide 5: Strategic partnership with Hologic

    Strategic partnership with Hologic • Hologic is a recognized global leader in women’s health based in Massachusetts, For personal use only US - NASDAQ: HOLX, Market Capitalization ~US$18 billion - FY2023 revenue of US$4.0 billion with net income of US$0.5 billion - Diagnostic products account for ~5

  6. Slide 6: New Major Development and IP Agreements with Hologic

    New Major Development and IP Agreements with Hologic The new Agreements build on work conducted by Lumos and Hologic over the last 12+ months and focus on the development of an improved version of one of Hologic's leading on market women's health products, including adapting it for use on Lumos’ For

  7. Slide 7: Questions

    For personal use only Questions © Lumos Diagnostics 2020, all rights reserved Confidential 7 Confidential 7

  8. Slide 8: For personal use only

    For personal use only www.lumosdiagnostics.com Confidential 8

Lumos Diagnostics Holdings — Investor Presentation (January 2024) on 6ix